top
Search terms
Results 1 - 4 of 4 - ordered by :
Escardio

OSLER-1 and OSLER-2 Clinical Trials Evolocumab, a monoclonal antibody that inhibits pro-protein convertase subtilisin-kexin type 9 (PCSK9), significantly reduced low-density lipoprotein (LDL) ...

Date : 20/10/2015
Escardio

Watch the webinar recording Course details After a introduction of 15 minutes to the topic, Professor Camm will submit practical cases based on the Afib Guidelines. John Camm 01-09-08 ESC CONGRESS ...

Date : 26/01/2011
Escardio

Rivaroxaban for stroke or TIA prevention in heart failure patients with sinus rhythm The results of the Commander HF trial about the effects of low dose Rivaroxaban in combination with antiplatelet ...

Date : 08/08/2019
Escardio

DOI 10.1093/ehjcvp/pvy038 Comment In this issue of European Heart Journal – Cardiovascular Phamacotherapy (Vol 5, Issue 1, January 2019), Dr Januzzi and co-workers from the USA report data from ...

Date : 31/01/2019